The present invention relates to naphthyridine and isoquinoline compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of CDK8/19, and for the treatment of CDK8/19-related disorders.
本发明涉及
萘啶和
异喹啉化合物,以及由此组成的药物可接受的组合物,作为CDK8/19的
抑制剂,用于治疗与CDK8/19相关疾病。